Carson Wealth (CWM LLC)’s AbCellera Biologics ABCL Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,512	Closed	-$18K	–	5340
2025 Q3	$18K	Buy	+3,512	New	+$15.5K	﹤0.01%	4179
2023 Q3	–	Sell	-730	Closed	-$5K	–	4141
2023 Q2	$5K	Buy	730 +408	+127%	+$2.78K	﹤0.01%	3407
2023 Q1	$2K	Buy	322 +295	+1,093%	+$2.68K	﹤0.01%	3601
2022 Q4	$0	Buy	+27	New	+$312	﹤0.01%	3933

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ABCL Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of AbCellera Biologics (ABCL) in Q4 2025, closing a stake of 3,512 shares — an estimated $18K sold.

Carson Wealth (CWM LLC) first reported a position in ABCL in Q4 2022 and held it in 4 quarters. The position peaked at $18K in Q3 2025. 144 funds tracked by Wall St. Rank hold ABCL as of Q4 2025.

Carson Wealth (CWM LLC) reported no remaining AbCellera Biologics position as of Q4 2025 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 3,512 AbCellera Biologics shares in Q4 2025, an estimated $18K.
Carson Wealth (CWM LLC) first reported a position in AbCellera Biologics in Q4 2022 and held it in 4 quarters.
Carson Wealth (CWM LLC)'s AbCellera Biologics position peaked at $18K in Q3 2025.
144 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.